Literature DB >> 9608813

Quality assurance of the serologic diagnosis of Chagas' disease.

E N Cura1, E L Segura.   

Abstract

A quality assurance program of the Chagas' disease laboratory network of Argentina has been conducted by the National Reference Center since 1988, with the aim of assessing the reliability of serologic test results. Chagas' disease is endemic in Argentina, but the prevalence of seropositivity for Trypanosoma cruzi among 18- to 20-year-old men decreased from 5.8% in 1981 to 1.8% in 1994. About 600 laboratories form the Chagas' disease laboratory network, with main central laboratories in each of the 24 provinces in Argentina. The quality assurance program promotes regular use of good laboratory practice and internal and external quality control to improve performance of the participants; it also provides technical assistance and guidelines. Eventual corrective measures are discussed in workshops. Results of the first external evaluation by proficiency testing of serum panels and confirmation of results for 58 of the main laboratories reveal that from 1988 to 1994 the rate of agreement has increased.

Entities:  

Mesh:

Year:  1998        PMID: 9608813     DOI: 10.1590/s1020-49891998000400004

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  3 in total

1.  Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina.

Authors:  Ana María De Rissio; Adelina Rosa Riarte; Miriam Martín García; Mónica Inés Esteva; Marta Quaglino; Andrés Mariano Ruiz
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

2.  Trypanosoma cruzi-specific immune responses in subjects from endemic areas of Chagas disease of Argentina.

Authors:  Gabriela C Olivera; Maria C Albareda; Maria G Alvarez; Ana M De Rissio; Laura E Fichera; Gretchen Cooley; Pedro Yachelini; Hugo A Hrellac; Hilda Riboldi; Susana A Laucella; Rick L Tarleton; Miriam Postan
Journal:  Microbes Infect       Date:  2010-02-01       Impact factor: 2.700

3.  High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection.

Authors:  Gretchen Cooley; R Drew Etheridge; Courtney Boehlke; Becky Bundy; D Brent Weatherly; Todd Minning; Matthew Haney; Miriam Postan; Susana Laucella; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2008-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.